Diabetes and Your Eyes: A Critical Warning for Punjab
Punjab has one of India's highest diabetes prevalence rates — estimated at 12–15% of the adult population — far exceeding the national average. This statistic carries a profound and often unrecognised consequence: diabetic retinopathy, the leading cause of preventable blindness in working-age adults worldwide.
What makes diabetic retinopathy particularly treacherous is its silence. In its early and even intermediate stages, it causes absolutely no symptoms — no pain, no redness, no vision change. Yet throughout this silent phase, high blood sugar is systematically destroying the delicate blood vessels of the retina. By the time a patient notices vision problems, the disease has typically progressed to a stage where treatment is more complex, recovery is slower, and vision loss may be permanent.
At Brar Eye Hospital Bathinda and Kotkapura, our retinal specialists see the devastating consequences of late-diagnosed diabetic retinopathy regularly — many cases that could have been preserved with early detection and treatment. This guide is our attempt to change that pattern in Punjab: to explain diabetic eye disease clearly, motivate regular screening, and ensure every diabetic patient in our community understands the sight-threatening risk they carry.
1 in 3
Diabetics Have Some DR
15%
Punjab Adult Diabetes Rate
#1
Preventable Blindness Cause in Working Adults
90%
Blindness Prevented with Early Treatment
How Does Diabetes Damage the Eye? The Pathophysiology
The retina has one of the highest metabolic demands of any tissue in the body — it requires an exceptional blood supply to sustain the constant activity of its millions of photoreceptors. The retinal vasculature (blood vessels) is exquisitely sensitive to the toxic effects of chronically elevated blood glucose.
High blood sugar damages retinal blood vessels through several mechanisms:
- Pericyte loss: Pericytes are structural support cells wrapping around retinal capillary walls. Glucose toxicity selectively destroys pericytes early in diabetes, weakening capillary walls
- Microaneurysm formation: Weakened capillary walls bulge out to form tiny balloon-like outpouchings (microaneurysms) — the earliest ophthalmoscopically visible sign of diabetic retinopathy
- Blood-retinal barrier breakdown: Damaged vessel walls become leaky, allowing fluid, lipids, and blood cells to seep into the retinal tissue
- Capillary occlusion: Abnormal blood cells and clotting factors block retinal capillaries, creating areas of retinal ischaemia (oxygen starvation)
- Neovascularisation: Ischaemic retina releases VEGF (vascular endothelial growth factor) — a signal protein that stimulates growth of new, abnormal blood vessels. These fragile new vessels proliferate on the retinal surface and into the vitreous gel, setting the stage for the most vision-threatening complications
Stages of Diabetic Retinopathy
Stage 1: Mild Non-Proliferative DR (NPDR)
The earliest stage — characterised by a few microaneurysms visible only on ophthalmoscopy. No visual symptoms whatsoever. Excellent prognosis with tight diabetes control. Annual monitoring sufficient.
Stage 2: Moderate Non-Proliferative DR
More extensive vascular changes — increased microaneurysms, dot and blot haemorrhages (small retinal bleeds), cotton-wool spots (areas of local nerve fibre ischaemia appearing as white fluffy patches). Still typically asymptomatic. Requires 6–12 monthly monitoring. Excellent blood sugar and blood pressure control can stabilise or even partially reverse this stage.
Stage 3: Severe Non-Proliferative DR
Significant retinal ischaemia present. Features include the "4-2-1 rule": haemorrhages in all 4 quadrants of the retina, venous beading (irregularity) in 2+ quadrants, and/or intraretinal microvascular abnormalities (IRMA) in 1+ quadrant. 50% of severe NPDR cases progress to proliferative DR within one year. Requires close monitoring every 3–4 months and consideration of pan-retinal laser photocoagulation.
Stage 4: Proliferative Diabetic Retinopathy (PDR)
New abnormal blood vessels (neovascularisation) grow on the retinal surface, optic disc, and into the vitreous. These fragile vessels bleed easily, causing vitreous haemorrhage (sudden dark floaters or complete vision blackout) and can create tractional scar tissue that pulls on the retina, causing tractional retinal detachment. PDR requires urgent treatment — pan-retinal laser photocoagulation and/or intravitreal anti-VEGF injections.
Diabetic Macular Edema (DME) – The Most Common Cause of Vision Loss
DME can occur at any stage of retinopathy — even in mild NPDR — and is the primary cause of vision impairment in diabetic patients. Fluid leaks from damaged blood vessels into the macula (the central, highest-resolution retina), causing swelling that distorts and blurs central vision. Symptoms include central blurring, straight lines appearing wavy or distorted, and difficulty reading. Treatment with intravitreal anti-VEGF injections is highly effective.
Risk Factors for Diabetic Retinopathy in Punjab
Not all diabetic patients develop retinopathy equally. Key risk factors include:
- Duration of diabetes: The most important risk factor. After 20 years of diabetes, approximately 90% of Type 1 and 60% of Type 2 patients have some degree of retinopathy
- Poor glycaemic control: Every 1% reduction in HbA1c reduces DR risk by 35%
- High blood pressure: Doubles the risk of vision-threatening retinopathy and accelerates all stages of progression
- High blood cholesterol and triglycerides: Associated with more severe hard exudates and macular involvement
- Pregnancy: Can accelerate DR progression — diabetic women planning pregnancy need intensive pre-conception retinal evaluation and monitoring throughout pregnancy
- Diabetic kidney disease: A marker of generalised microvasculopathy — patients with nephropathy are at higher risk of severe DR
- Smoking: Constricts retinal blood vessels and worsens tissue oxygenation
- Anaemia: Common in Punjab's female population — worsens retinal ischaemia
Symptoms of Diabetic Retinopathy
This is the critical point that cannot be emphasised strongly enough: diabetic retinopathy causes NO symptoms in early and moderate stages. By the time vision is affected, significant irreversible damage has usually occurred. Symptoms that may eventually develop include:
- Blurred or fluctuating vision (DME)
- Sudden appearance of dark floaters or "cobwebs" (vitreous haemorrhage)
- Dark or empty areas in central vision (macular damage)
- Difficulty with colour perception
- Sudden, complete, painless vision loss in one eye (massive vitreous haemorrhage or retinal detachment)
Diagnosis: Why Annual Screening Is Non-Negotiable
At Brar Eye Hospital, diabetic retinopathy screening includes:
- Best corrected visual acuity: Baseline assessment
- Dilated fundus examination: Binocular indirect ophthalmoscopy — examines the full retina to the periphery
- OCT (Optical Coherence Tomography): Detects and quantifies macular edema with micron precision — essential for DME diagnosis and treatment monitoring
- Fundus photography: Documents retinal status for comparison over time
- Fluorescein angiography (FFA): Maps retinal blood vessel integrity, identifies leakage zones, and guides laser treatment
- B-scan ultrasonography: When dense vitreous haemorrhage obscures the retinal view
Treatment of Diabetic Retinopathy at Brar Eye Hospital
1. Systemic Control – The Foundation of Everything
No ocular treatment is effective without excellent systemic diabetes management. The most powerful intervention for diabetic retinopathy is achieving and maintaining target HbA1c (below 7% ideally), blood pressure below 130/80 mmHg, and LDL cholesterol below 100 mg/dL. Regular consultation with your diabetologist is as important as your ophthalmology visits.
2. Intravitreal Anti-VEGF Injections
Currently the gold standard treatment for diabetic macular edema and proliferative DR. Anti-VEGF agents (ranibizumab/Accentrix, bevacizumab/Avastin, aflibercept/Eylea) are injected directly into the vitreous cavity, blocking the VEGF protein that drives both macular edema and neovascularisation. Treatment typically begins with monthly injections for 3–6 months, then transitions to a treat-and-extend or PRN (as-needed) protocol. Results are often dramatic — significant vision improvement is common.
3. Laser Photocoagulation
- Pan-Retinal Photocoagulation (PRP): Laser burns applied to the peripheral retina destroy ischaemic tissue, reducing VEGF production and causing regression of neovascularisation. Used for PDR. May reduce some peripheral and night vision but prevents more devastating central vision loss
- Focal/Grid Laser: Targets specific leaking vessels in the macula. Less commonly used as a primary treatment for DME now that anti-VEGF is available, but remains a useful adjunctive tool
4. Vitreoretinal Surgery
Required when conservative treatments cannot address the underlying pathology: vitrectomy for non-clearing vitreous haemorrhage (when laser cannot penetrate to treat the retina), and for tractional retinal detachment involving the macula. Advanced vitreoretinal surgery at Brar Eye Hospital uses 23-gauge and 25-gauge minimally invasive vitrectomy systems.
Can Diabetic Retinopathy Be Prevented?
Complete prevention requires controlling diabetes itself — but the following significantly reduce risk and slow progression:
- Strict HbA1c control: Maintain below 7% — every percentage point reduction makes a measurable difference
- Blood pressure management: Target below 130/80 mmHg — use prescribed medications consistently
- Annual dilated fundus examination from the time of diabetes diagnosis — the most important preventive action
- Cholesterol management: Take prescribed statins; reduce dietary saturated fat
- Stop smoking — immediately and completely
- Regular physical activity: 30 minutes of moderate exercise daily significantly improves blood sugar control
- Healthy diet: Low glycaemic index foods, avoid refined carbohydrates and sugary drinks
- Maintain healthy weight: Obesity worsens insulin resistance and glycaemic control
Frequently Asked Questions – Diabetic Retinopathy
My vision is normal — do I still need a retinal exam if I have diabetes?
Absolutely yes. Normal vision does not rule out significant diabetic retinopathy. The early and moderate stages produce no visual symptoms while the retina is being progressively damaged. By the time vision is affected, treatment options are more limited and visual recovery less complete. Annual dilated retinal examination is the standard of care for ALL diabetic patients regardless of visual symptoms — it is the only way to detect disease before it causes permanent damage.
How many anti-VEGF injections will I need?
Treatment regimens vary by disease severity and treatment response. Most patients with DME start with monthly injections for 3 months (loading dose), then switch to a treat-and-extend protocol where injection intervals are gradually lengthened based on OCT findings. Long-term, many patients need injections every 2–4 months indefinitely, while some achieve disease stability with less frequent treatment. The frequency should always be guided by your retinal specialist based on your OCT scans — not by symptoms alone.
Will my vision come back after diabetic retinopathy treatment?
It depends on the stage and duration of the disease. Anti-VEGF treatment for DME can improve vision by 10–15 letters on the visual chart (a dramatic improvement) in many patients, particularly when started early. Vision stabilisation — preventing further loss — is the realistic goal for more advanced cases. Vision already lost from retinal ischaemia, extensive macular damage, or long-standing traction cannot be restored. This underscores the immense importance of early detection and treatment — before vision loss occurs, not after.
Can Type 2 diabetics develop diabetic retinopathy?
Absolutely — Type 2 diabetics are at equal risk of retinopathy. In fact, because Type 2 diabetes often goes undiagnosed for years before detection, many patients have significant retinopathy at the time of their diabetes diagnosis. Studies show 20–30% of newly diagnosed Type 2 diabetics already have some degree of retinopathy. This is why retinal examination should happen immediately when diabetes is first diagnosed, not years later.
Brar Eye Hospital Medical Team
Diabetic retinopathy specialists. Anti-VEGF, PRP laser & vitrectomy. NABH accredited. Bathinda & Kotkapura.
